Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Noninvasive Drug Delivery

Bob Butchofsky, CEO of Mati Therapeutics, speaks with Mark Kontos, MD, regarding the company and the products it has in the pipeline. Mr. Butchofsky provides an overview of a punctal plug drug delivery system for anterior segment diseases that is currently in development. He also shares insight into how the ocular therapeutics market may shift from eye drops to noninvasive drug delivery.

Anterior Segment • Anterior segment • Drug Delivery • Mati Therapeutics • Therapeutic drug delivery

11 / 72 Series: Ophthalmology Insider

More Videos in this Series